CRP and familial dilated cardiomyopathy: These findings suggest that a comprehensive assessment of inflammatory burden in DCM may contribute to improved risk stratification and earlier recognition of high-risk patients, although prospective studies are needed before the DNI–CRP axis can be incorporated into routine therapeutic decision-making.